Optimizing The Genome Editing Workflow With Microfluidic Technology

A recent grant collaboration, funded by Innovate UK, between Sphere Fluidics, University of Edinburgh, Horizon Discovery, OXGENE, and Twist Bioscience has culminated in a prototype automated microfluidic genome editing platform.

The benchtop device integrates and miniaturizes the multi-step process for creating genome-edited cell lines, from transfection to validation of the edited cell.

Dr. Steven Pollard, University of Edinburgh

To learn more, we spoke with Professor Steven Pollard, Group Leader at the Centre for Regenerative Medicine and Edinburgh Cancer Research Centre at the University of Edinburgh. We also discuss some of his latest work to understand the biology of brain cancer using CRISPR/Cas technology and optimized genome editing workflows.

Read the full interview here!

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sphere Fluidics. (2021, March 12). Optimizing The Genome Editing Workflow With Microfluidic Technology. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20210312/Optimizing-The-Genome-Editing-Workflow-With-Microfluidic-Technology.aspx.

  • MLA

    Sphere Fluidics. "Optimizing The Genome Editing Workflow With Microfluidic Technology". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20210312/Optimizing-The-Genome-Editing-Workflow-With-Microfluidic-Technology.aspx>.

  • Chicago

    Sphere Fluidics. "Optimizing The Genome Editing Workflow With Microfluidic Technology". News-Medical. https://www.news-medical.net/news/20210312/Optimizing-The-Genome-Editing-Workflow-With-Microfluidic-Technology.aspx. (accessed April 25, 2024).

  • Harvard

    Sphere Fluidics. 2021. Optimizing The Genome Editing Workflow With Microfluidic Technology. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20210312/Optimizing-The-Genome-Editing-Workflow-With-Microfluidic-Technology.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sphere Fluidics appoints Kenneth Hitchner as Chairman of its Board of Directors